N-(Pyridin-3-yl)-3-(3-chlorophenyl)-4-methoxybenzylamine

ID: ALA4520930

PubChem CID: 141732285

Max Phase: Preclinical

Molecular Formula: C19H17ClN2O

Molecular Weight: 324.81

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  COc1ccc(CNc2cccnc2)cc1-c1cccc(Cl)c1

Standard InChI:  InChI=1S/C19H17ClN2O/c1-23-19-8-7-14(12-22-17-6-3-9-21-13-17)10-18(19)15-4-2-5-16(20)11-15/h2-11,13,22H,12H2,1H3

Standard InChI Key:  HMLQGSOASZZTCS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
    4.5922  -23.8141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5910  -24.6336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2991  -25.0426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0088  -24.6331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0059  -23.8105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2973  -23.4052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8849  -25.0419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1772  -24.6311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4697  -25.0384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4686  -25.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1810  -26.2655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8856  -25.8558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7171  -25.0406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4242  -24.6309    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1325  -25.0384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1292  -25.8540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8367  -26.2614    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5447  -25.8517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5408  -25.0303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8327  -24.6266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8844  -23.4056    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8842  -22.5885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1832  -27.0827    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  2  7  1  0
  4 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  1 21  1  0
 21 22  1  0
 11 23  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4520930

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 324.81

Molecular Weight (Monoisotopic): 324.1029

AlogP: 5.02

#Rotatable Bonds: 5

Polar Surface Area: 34.15

Molecular Species: NEUTRAL

HBA: 3

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 3

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 5.45

CX LogP: 4.05

CX LogD: 4.04

Aromatic Rings: 3

Heavy Atoms: 23

QED Weighted: 0.71

Np Likeness Score: -1.26

References

1. Tang L, Huang C, Zhong J, He J, Guo J, Liu M, Xu JP, Wang HT, Zhou ZZ..  (2019)  Discovery of arylbenzylamines as PDE4 inhibitors with potential neuroprotective effect.,  168  [PMID:30822711] [10.1016/j.ejmech.2019.02.026]

Source

Source(1):

• Scientific Literature